Welcome to the June 2026 edition of the podcast. We are tackling all of our favourite subjects - PE, trauma, stroke, COVID, contrast controversies and

Welcome to the June 2026 edition of the podcast. We are tackling all of our favourite subjects - PE, trauma, stroke, COVID, contrast controversies and prehistoric dentistry. What more could you ask for in a podcast? SO have a listen, read the free PDFs below, and you too could save a life or at least relieve your friend's dental pain with some stone tools.

ARISE FLUIDS: a “negative” trial that might just be telling us something useful Peake SL, Macdonald SPJ, et al; the ARISE FLUIDS Investigators, the ANZICS

ARISE FLUIDS: a “negative” trial that might just be telling us something useful Peake SL, Macdonald SPJ, et al; the ARISE FLUIDS Investigators, the ANZICS Clinical Trials Group, and the ACEM Clinical Trials Network. Vasopressors or Fluids in Early Septic Shock. N Engl J Med. Published online June 11, 2026. DOI: 10.1056/NEJMoa2516225. (FREE PDF COPY HERE) We’ve spent fifteen years slowly walking back the idea that septic shock is a problem you solve by drowning it.

It’s 0200 in a rural ED. Sixty-three-year-old bloke, let’s call him Gary. He’s come in feeling a bit flat, mildly short of breath, no fever, no rigors. He looks okay. Obs are almost okay — HR 98, BP 118/76, RR 18, sats 96% on room air, temp 37.4. You’re thinking COPD exacerbation, maybe early LVF. You’re not thinking sepsis. Then the VBG comes back.

This is a re-release of one of my favourite lectures. When I was invited to speak at SMACC Gold 2015 I was given a free range to speak about whatever I

This is a re-release of one of my favourite lectures. When I was invited to speak at SMACC Gold 2015 I was given a free range to speak about whatever I desired. Daunting, to be given this choice as it is easy to do something easy, something that has hard science... so I chose the difficult path of trying to sell the concept of…

Only a few weeks have passed since I last wrote about negative trials for invasive therapy in pulmonary embolism. You wouldn’t think I would need to spend more time talking about negative research, but the HI-PETHO trial is different, because it is reported as positive, and some people seem to agree. Let’s review the details so you don’t fall into the same trap. 

It's 0200. You're the only doctor in a hospital five hours from the nearest trauma centre. A 24-year-old woman arrives via ambulance after a high-speed

It's 0200. You're the only doctor in a hospital five hours from the nearest trauma centre. A 24-year-old woman arrives via ambulance after a high-speed rollover. GCS 14. HR 118. BP 94 systolic. Seatbelt sign across the abdomen. She says she might be pregnant — maybe six weeks, maybe not at all. She's not sure. And somewhere in the room, the hesitation begins.

Emergency physicians pride themselves on recognizing and treating life-threatening illness under pressure. Yet one of the most lethal, common, and treatable conditions presenting to our EDs still ofte...

Despite incredibly underwhelming evidence from the outset, a massive amount of money was spent (or wasted) on Paxlovid during the COVID pandemic. Some of the issues are endemic to medical science. Whe...

Another great talk from the SSEM Conference in Broome. My co-conspirator (organiser) Mr Kane Guthrie delivered a chat on his favourite topic - refractory

Another great talk from the SSEM Conference in Broome. My co-conspirator (organiser) Mr Kane Guthrie delivered a chat on his favourite topic - refractory

Another great talk from the SSEM Conference in Broome. My co-conspirator (organiser) Mr Kane Guthrie delivered a chat on his favourite topic - refractory shock. This is a talk about what we need to know and do in the patient in Resus that doesn't get better with the usual first line therapies. If this interests you then you should also check out Justin's post on "When Norepinepherine isn't working..."

In this video I go over my old SMACC Dublin Diagnsotics talk and revisit the Bayesian reasoning that lays at the heart of what we do in the ED.  If you

In this video I go over my old SMACC Dublin Diagnsotics talk and revisit the Bayesian reasoning that lays at the heart of what we do in the ED.  If you ned to go back and listen to the original talk, its worth the visit - all you need to know about Bayes' theorum for ED docs in 22 minutes!

The May edition of the Journal Club is out now! This is a long podcast, but packed full of fun EBM and some practice changing papers and we even manage to

The May edition of the Journal Club is out now! This is a long podcast, but packed full of fun EBM and some practice changing papers and we even manage to escape our usual evidentiary nihilism. Links are in the description below to the PDFs and you can listen on your favourite app or just watch the video on Youtube…

So that is the most ridiculous title that I have ever employed on this blog. Avalanches... Broome.. has Casey finally lost the plot? Well, maybe - but I blame Dr Morgenstern. He sent me an article to review for this month's Journal Club and it forced me down a deep rabbit hole into a snowy academia that I never knew existed.

This talk is from the Spring Sessions in EM conference in Broome last year. I invited my mate Scott Weingart to "virtually work in Broome ED" for a shift.

This talk is from the Spring Sessions in EM conference in Broome last year. I invited my mate Scott Weingart to "virtually work in Broome ED" for a shift. This was a lot of fun - we talk about a lot of the minutiae of realistic Resus in a rural ED and how we can translate the evidence to make things work in our practice. There are many pearls in here - everything from when to tube to how to move in a resource limited environment. Enjoy!

Casey Parker | BroomeDocs | April 2026 The modern management of proper pulmonary embolism (not the common little ones) has been evolving rapidly in the